68 studies found for:    Enzalutamide
Show Display Options
Rank Status Study
1 Completed Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patients
Conditions: Prostate Cancer;   Pharmacokinetics of Enzalutamide
Interventions: Drug: Enzalutamide tablet;   Drug: Enzalutamide capsule
2 Completed A Study to Evaluate How a Drug That Alters Liver Enzymes (Rifampin) Affects the Metabolism of Enzalutamide in Men
Conditions: Drug-Drug Interaction (DDI);   Healthy Subjects;   Pharmacokinetics of Enzalutamide
Interventions: Drug: enzalutamide;   Drug: rifampin
3 Completed A Study to Compare Capsule and Tablet Forms of MDV3100 (Enzalutamide) After Administration of a Single Set Dose Under Fasted Conditions in Healthy Male Subjects
Conditions: Healthy Subjects;   Castration Resistant Prostate Cancer (CRPC);   Relative Bioavailability;   MDV3100
Intervention: Drug: MDV3100
4 Completed A Study to Investigate the Effect of Severely Diminished Liver Function on the Metabolism, Safety, and Tolerability of a Single Oral Dose of Enzalutamide in Men
Conditions: Severe Hepatic Impairment;   Normal Hepatic Function
Intervention: Drug: enzalutamide
5 Recruiting Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer
Condition: Breast Cancer
Intervention: Drug: enzalutamide
6 Completed Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates
Conditions: Castration Resistant Prostate Cancer (CRPC);   Pharmacokinetics of MDV3100
Interventions: Drug: MDV3100;   Drug: Pioglitazone;   Drug: Warfarin;   Drug: Omeprazole;   Drug: Midazolam
7 Recruiting Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Enzalutamide;   Drug: exemestane;   Drug: Placebo (for enzalutamide)
8 Recruiting Enzalutamide in Patients With High-risk Prostate Cancer
Condition: Adenocarcinoma of the Prostate
Intervention: Drug: enzalutamide
9 Recruiting Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer
Conditions: Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: enzalutamide;   Drug: mifepristone;   Other: laboratory biomarker analysis;   Other: pharmacological study
10 Completed Drug-drug Interaction Study With MDV3100 (ASP9785) and Gemfibrozil and Itraconazole
Conditions: Healthy Subjects;   Pharmacokinetics;   Drug-Drug Interaction
Interventions: Drug: MDV3100;   Drug: Gemfibrozil;   Drug: Itraconazole
11 Recruiting Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patients
Condition: Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Abiraterone;   Drug: Placebo for Enzalutamide;   Drug: Prednisone
12 Active, not recruiting A Study to Determine Safety and Tolerability of Enzalutamide (MDV3100) in Combination With Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer Patients
Condition: Metastatic Castration-Resistant Prostate Cancer
Interventions: Drug: enzalutamide;   Drug: abiraterone acetate;   Drug: prednisone
13 Recruiting RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistant (The RESTORE Study)
Condition: Prostate Cancer
Interventions: Drug: Testosterone cypionate;   Drug: Testosterone Enanthate;   Drug: Abiraterone acetate;   Drug: Enzalutamide
14 Completed A Study to Explore the Routes of Elimination of MDV3100
Conditions: Healthy Subjects;   Pharmacokinetics of MDV3100
Intervention: Drug: MDV3100
15 Not yet recruiting A Study to Monitor the Safety of Enzalutamide in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
Conditions: Prostate Cancer;   Castration-Resistant Prostate Cancer
Intervention: Drug: Enzalutamide
16 Not yet recruiting Enzalutamide Plus Everolimus in Men With Metastatic Castrate-Resistant Prostate Cancer and Previous Treatment With Docetaxel
Condition: Prostate Cancer, Castrate-resistant
Interventions: Drug: Everolimus;   Drug: Enzalutamide
17 Recruiting Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM)
Condition: Prostate Cancer
Interventions: Drug: enzalutamide;   Drug: Androgen Deprivation;   Radiation: Radiation Therapy
18 Completed Hepatic Impairment Study With MDV3100 in Subjects With Mild and Moderate Hepatic Impairment Compared to a Healthy Control Group
Conditions: Pharmacokinetics of MDV3100;   Healthy Subjects;   Kidney Diseases
Intervention: Drug: MDV3100
19 Recruiting Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy
Conditions: Adenocarcinoma of the Prostate;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: enzalutamide;   Other: laboratory biomarker analysis
20 Recruiting Enzalutamide + External Beam Rt For Prostate
Condition: Intermediate Risk Prostate Cancer
Interventions: Drug: Enzalutamide;   Radiation: External Beam Radiation

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years